About us
Meet the team
At metaLead, we aim to develop innovative, safe and effective medications for metal-related diseases, enhancing patient’s quality of life. Our vision is to revolutionize chelation therapy; to ensure that our medications will become first-in-line treatments for various indications and conditions.
Michal Shoshan
Founder and CEO
Medicinal inorganic chemist
Itay Shalital
Head of Finance
Finance, legal & strategy
Tagwa Mohammed
Scientist
Medicinal inorganic chemist
Luca Sauser
Scientist
Medicinal inorganic chemist
Yaël Hodel
Research Associate
Health science & technology, neuroscience
Deniz Queisser
Research Associate
Neuroscience, in vivo
Our board
Michal Shoshan
Chairwoman of the Board
David Urech
Board Member
They trust us!
We are supported by top institutions within Switzerland and beyond, among them:
James Martin | Company name
